Goddard Glenn - Insider Non-Derivative Transactions at Intellia Therapeutics, Inc. (NTLA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 1, 2024, Goddard Glenn's relationship to Intellia Therapeutics, Inc. (NTLA) is Officer (EVP, Chief Financial Officer), and currently has 69,213 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NTLA insiders.
Data Source: SEC.
Goddard Glenn - Insider Non-Derivative Transactions of NTLA Common Stock
Goddard Glenn - Insider Non-Derivative Transactions at NTLA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 2, 2024 | Acquisition -- (Common Stock) | 28628 | 0 | 69213 |
| Jan 4, 2024 | Sell -- (Common Stock) | 5365 | 29.46 | 40585 |
| Jan 2, 2024 | M -- (Common Stock) | 3062 | 0 | 45950 |
| Mar 2, 2023 | Acquisition -- (Common Stock) | 27484 | 0 | 42888 |
| Jan 5, 2023 | Sell -- (Common Stock) | 2427 | 37.21 | 15404 |
| Jan 2, 2023 | M -- (Common Stock) | 3062 | 0 | 17831 |